Peijia Medical
Market Cap
HK$18.5b
Last Updated
2021/01/23 10:06 UTC
Data Sources
Company Financials +
Executive Summary
Peijia Medical Limited engages in the research, development, production, and sales of interventional procedural medical devices for the treatment of structural heart and neurovascular diseases. More Details
Rewards
Risk Analysis
Snowflake Analysis
Excellent balance sheet and slightly overvalued.
Share Price & News
How has Peijia Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 9996 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: 9996's weekly volatility (9%) has been stable over the past year.
Market Performance
7 Day Return
7.9%
9996
10.9%
HK Medical Equipment
3.5%
HK Market
1 Year Return
n/a
9996
113.9%
HK Medical Equipment
15.1%
HK Market
Return vs Industry: Insufficient data to determine how 9996 performed against the Hong Kong Medical Equipment industry.
Return vs Market: Insufficient data to determine how 9996 performed against the Hong Kong Market.
Shareholder returns
| 9996 | Industry | Market | |
|---|---|---|---|
| 7 Day | 7.9% | 10.9% | 3.5% |
| 30 Day | 14.5% | 12.5% | 12.7% |
| 90 Day | 7.7% | 20.7% | 18.1% |
| 1 Year | n/a | 117.3%113.9% | 19.7%15.1% |
| 3 Year | n/a | 223.3%207.7% | -5.1%-15.1% |
| 5 Year | n/a | 353.3%314.9% | 65.1%37.0% |
Long-Term Price Volatility Vs. Market
How volatile is Peijia Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 weeks ago | Simply Wall St
We Think Peijia Medical (HKG:9996) Can Afford To Drive Business Growth2 months ago | Simply Wall St
What Type Of Shareholders Own The Most Number of Peijia Medical Limited (HKG:9996) Shares?4 months ago | Simply Wall St
We're Hopeful That Peijia Medical (HKG:9996) Will Use Its Cash WiselyValuation
Is Peijia Medical undervalued compared to its fair value and its price relative to the market?
26.9%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 9996 (HK$29.3) is trading below our estimate of fair value (HK$40.08)
Significantly Below Fair Value: 9996 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 9996 is unprofitable, so we can't compare its PE Ratio to the HK Medical Equipment industry average.
PE vs Market: 9996 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 9996's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 9996 is overvalued based on its PB Ratio (5x) compared to the HK Medical Equipment industry average (3.9x).
Next Steps
Future Growth
How is Peijia Medical forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
55.4%
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 9996's forecast earnings growth is above the savings rate (1.5%).
Earnings vs Market: Insufficient data to determine if 9996's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 9996's revenue (55.4% per year) is forecast to grow faster than the Hong Kong market (14.4% per year).
High Growth Revenue: 9996's revenue (55.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9996's Return on Equity is forecast to be low in 3 years time (3%).
Next Steps
Past Performance
How has Peijia Medical performed over the past 5 years?
-613.2%
Last years earnings growth
Earnings and Revenue History
Quality Earnings: 9996 is currently unprofitable.
Growing Profit Margin: 9996 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 9996's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare 9996's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 9996 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.7%).
Return on Equity
High ROE: 9996 has a negative Return on Equity (-70.35%), as it is currently unprofitable.
Next Steps
Financial Health
How is Peijia Medical's financial position?
Financial Position Analysis
Short Term Liabilities: 9996's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥42.1M).
Long Term Liabilities: 9996's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥24.5M).
Debt to Equity History and Analysis
Debt Level: 9996 is debt free.
Reducing Debt: 9996 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 9996 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 9996 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Next Steps
Dividend
What is Peijia Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 9996's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 9996's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 9996's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 9996's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 9996's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.6yrs
Average management tenure
CEO
Zhang Yi (51 yo)
no data
Tenure
Dr. Zhang Yi has been an Executive Director of Peijia Medical Limited since May 30, 2012. He serves as the Chairman, Chief Executive Officer; Chief Technology Officer at Peijia Medical Limited. He served a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | no data | no data | 0.83% CN¥ 153.3m | |
| Chief Financial Officer | 1.75yrs | no data | no data | |
| Chief Operating Officer | 3.42yrs | no data | 0.70% CN¥ 130.4m | |
| Director of Sales | 0.75yr | no data | no data | |
| Director of Marketing | 1.5yrs | no data | no data | |
| Director of Human Resources | 1.17yrs | no data | no data | |
| Executive Director | 2.42yrs | no data | 0.16% CN¥ 29.9m | |
| Executive Director & Company Secretary | 8.25yrs | no data | 2.32% CN¥ 430.4m | |
| Company Secretary | no data | no data | no data | |
| Vice President of Advanced Technology | no data | no data | 0.35% CN¥ 64.5m |
1.6yrs
Average Tenure
43.5yo
Average Age
Experienced Management: 9996's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | no data | no data | 0.83% CN¥ 153.3m | |
| Executive Director | 2.42yrs | no data | 0.16% CN¥ 29.9m | |
| Executive Director & Company Secretary | 8.25yrs | no data | 2.32% CN¥ 430.4m | |
| Independent Non-executive Director | 1yr | no data | no data | |
| Independent Non-executive Director | 1yr | no data | no data | |
| Independent Non-executive Director | 1yr | no data | no data | |
| Non-executive Director | 1.58yrs | no data | no data | |
| Independent Non-executive Director | 1yr | no data | no data | |
| Non-executive Director | 4.83yrs | no data | no data | |
| Non-executive Director | 1.25yrs | no data | no data | |
| Non-Executive Director | 0.42yr | no data | no data |
1.1yrs
Average Tenure
51yo
Average Age
Experienced Board: 9996's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: 9996 only recently listed within the past 12 months.
Top Shareholders
Company Information
Peijia Medical Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Peijia Medical Limited
- Ticker: 9996
- Exchange: SEHK
- Founded: 2012
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: HK$18.544b
- Shares outstanding: 632.92m
- Website: https://www.peijiamedical.com
Number of Employees
Location
- Peijia Medical Limited
- 8 Zhongtian Street
- Suzhou Industrial Park
- Suzhou
- Jiangsu Province
- 215028
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 4WO | DB (Deutsche Boerse AG) | Yes | Domestic Shares | DE | EUR | May 2020 |
| 9996 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Domestic Shares | HK | HKD | May 2020 |
| 9996 | SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect) | Yes | Domestic Shares | HK | HKD | May 2020 |
| 9996 | SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect) | Yes | Domestic Shares | HK | HKD | May 2020 |
Biography
Peijia Medical Limited engages in the research, development, production, and sales of interventional procedural medical devices for the treatment of structural heart and neurovascular diseases. Its product...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/23 10:06 |
| End of Day Share Price | 2021/01/22 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.